These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2784745)

  • 21. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcus aureus Wood 46 strain activates human B cells without affecting DNA synthesis or tyrosine phosphorylation.
    Saiki O; Kawamoto M; Fukuzumi M; Kanou M; Utsumi S
    J Immunol; 1993 Apr; 150(8 Pt 1):3224-9. PubMed ID: 8468467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
    London L; Perussia B; Trinchieri G
    J Immunol; 1986 Dec; 137(12):3845-54. PubMed ID: 3491151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
    Vine JB; Geppert TD; Lipsky PE
    J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.
    Defrance T; Vanbervliet B; Pène J; Banchereau J
    J Immunol; 1988 Sep; 141(6):2000-5. PubMed ID: 2971718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
    Gajewski TF; Fitch FW
    J Immunol; 1988 Jun; 140(12):4245-52. PubMed ID: 2967332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and functional characteristics of human newborns' B lymphocytes.
    Durandy A; Thuillier L; Forveille M; Fischer A
    J Immunol; 1990 Jan; 144(1):60-5. PubMed ID: 1688576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are cord blood B cells functionally mature?
    Tucci A; Mouzaki A; James H; Bonnefoy JY; Zubler RH
    Clin Exp Immunol; 1991 Jun; 84(3):389-94. PubMed ID: 2044218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
    Durandy A; De Saint Basile G; Lisowska-Grospierre B; Gauchat JF; Forveille M; Kroczek RA; Bonnefoy JY; Fischer A
    J Immunol; 1995 Feb; 154(4):1560-8. PubMed ID: 7530739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis.
    Huston MM; Moore JP; Mettes HJ; Tavana G; Huston DP
    J Immunol; 1996 Feb; 156(4):1392-401. PubMed ID: 8568239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides.
    Tvede N; Heilmann C; Christensen LD
    Clin Exp Immunol; 1989 Jun; 76(3):404-11. PubMed ID: 2787716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 2 induces T cell-dependent IgM production in human B cells.
    Sauerwein RW; Van der Meer WG; Dräger A; Aarden LA
    Eur J Immunol; 1985 Jun; 15(6):611-6. PubMed ID: 3874074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
    Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
    Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.